GGrantIndex
Sort

46,585 grants matching heart failure

Fatty Acids and Heart Failure in the Physicians' Health Study

$694,451
Luc Djousse · Brigham And Women'S Hospital · R01 · FY2010 · HL

Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot

$694,289
Bernhard Kuhn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury

$694,270
Joachim H Ix · University Of California, San Diego · R01 · FY2022 · DK

Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension

$694,268
Hongyu Qiu · Georgia State University · R01 · FY2020 · HL

Mechanisms of cardioprotective Y RNA signaling in macrophages

$694,252
Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2025 · HL

Cardiac Exosomes in myocardial Ischemic injury

$694,229
Jochen Daniel Muehlschlegel · Brigham And Women'S Hospital · R01 · FY2021 · HL

Tissue-engineered pulmonic valve grown from human cells for pediatric patients

$694,222
Robert T Tranquillo · University Of Minnesota · R01 · FY2014 · HL

Transforming Care Delivery Models for at-Risk Young Adult Patients with Congenital Heart Disease and Amplifying Research Efforts to Improve Health Equity in Pediatric Chronic Disease Care

$694,198
Keila Natilde Lopez · Baylor College Of Medicine · R01 · FY2024 · MD

Understanding and addressing risks of low socioeconomic status and diabetes for heart failure

$694,188
Chiadi E Ndumele · Johns Hopkins University · P50 · FY2022 · MD

Dynamic Longitudinal Functional Models with Applications to the CRIC Study

$694,185
Wensheng Guo · University Of Pennsylvania · R01 · FY2025 · HL

Sustaining Home Palliative Care for Patients with Heart Failure (HF) and Their Family Caregivers in Rural Appalachia: A Mixed Methods Randomized Clinical Trial (RCT)

$694,132
Ubolrat Piamjariyakul · West Virginia University · R01 · FY2024 · NR

Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response

$694,067
Brian Jesse Debosch · Washington University · R01 · FY2020 · HL

Exploration of Arrhythmogenic Triggers and Substrates in Heart Failure

$694,016
Natalia A. Trayanova · Johns Hopkins University · R01 · FY2017 · HL

Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease

$693,992
Brad C Astor · Johns Hopkins University · R01 · FY2009 · DK

Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEF

$693,938
Payman Zamani · University Of Pennsylvania · R01 · FY2023 · HL

Risk Thresholds of Alcohol and Polysubstance Use Among Older Adults

$693,883
Katherine Joann Hoggatt · Northern California Institute/Res/Edu · R56 · FY2021 · AG

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

$693,855
Connie Meeyoung Rhee · University Of California-Irvine · R01 · FY2019 · DK

Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending

$693,853
Ali Moghtaderi · George Washington University · R01 · FY2021 · HL

Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data

$693,790
Paul Englund Drawz · University Of Minnesota · R01 · FY2021 · HL

Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV

$693,765
Jennifer Jao · Lurie Children'S Hospital Of Chicago · R01 · FY2023 · HL

ACE Inhibition and Novel Cardiovascular Risk Factors

$693,661
Wake Forest University Health Sciences · R01 · FY2002 · HL

Retinoid Metabolism in the Adult Heart and Heart Failure

$693,576
D Brian Foster · Johns Hopkins University · R01 · FY2024 · HL

RE-ENERGIZE FONTAN - RandomizEd Exercise INtERvention desiGned to MaximIZE Fitness in Pediatric FONTAN patients

$693,515
Elif Seda Selamet Tierney · Stanford University · R33 · FY2023 · HL

Mechanism of Chemotherapy Induced Microvascular Dysfunction in Cancer Survivors

$693,424
Andreas M Beyer · Medical College Of Wisconsin · R01 · FY2024 · HL

Genotype-guided therapy for atrial fibrillation

$693,420
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2021 · HL